AddLife ALIF B.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker ALIF B.ST. It has been listed since 16 March 2015. In the fiscal year to 31 December 2025, it reported revenue of SEK 10.44bn and net income of SEK 560.0m. At that date it held total assets of SEK 12.71bn and shareholders' equity of SEK 5.44bn.

AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Johan SjoeIndependent Chairman of the BoardSEK 730,000
• Mr. Fredrik DalborgPresident, Chief Executive OfficerSEK 10.3m
• Ms. Christina RubenhagChief Financial Officer
• Ms. Eva ElmstedtIndependent DirectorSEK 360,000
• Mr. Stefan HedeliusIndependent DirectorSEK 360,000
• Ms. Eva NilsagardIndependent DirectorSEK 430,000
• Ms. Birgit NorinderIndependent DirectorSEK 360,000
• Mr. Hakan RoosIndependent DirectorSEK 360,000

Overall

52

Environment

34

Social

66

Governance

55

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.